A study of V205C at mumps expiry potency in healthy children 12 to 18 months of age

Trial Profile

A study of V205C at mumps expiry potency in healthy children 12 to 18 months of age

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Nov 2009

At a glance

  • Drugs MMR-varicella zoster virus vaccine; Varicella vaccines
  • Indications Chickenpox; Measles; Mumps; Rubella
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 Nov 2009 Investigational drug (Varicella Virus Vaccine Live), actual patient number (1997) added as reported by ClinicalTrials.gov.
    • 03 Nov 2009 Actual end date (1 Jul 2001) added as reported by ClinicalTrials.gov.
    • 03 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top